These preliminary data support the hypothesis that negative 68Ga-PET/CT, reflecting a lower degree of neuroendocrine differentiation [19, 20], may be associated with the PD-NEC subgroup that frequently harbors an RB1 mutation and loss of its expression [8]. The gene discussed is RB1; the disease is neuroendocrine carcinoma.